Abstract
Nussinov et al. describe that the mechanism of mutational activation of kinases differs from Ras. Drug action should relate to the mechanism of activation, not to whether the protein is in active or inactive state. However, allosterically blocking the functional site will work for the inactive kinase and active Ras.
Original language | English |
---|---|
Pages (from-to) | 121-133 |
Number of pages | 13 |
Journal | Cell Chemical Biology |
Volume | 28 |
Issue number | 2 |
DOIs | |
State | Published - 18 Feb 2021 |
Keywords
- K-Ras4B
- KRAS
- dimer
- drug discovery
- energy landscape
- inhibitor
- kinases